⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8561554 | 0.61 | — | — | |
| SCHEMBL9978448 | 0.59 | — | — | |
| SCHEMBL199624 | 0.59 | — | — | |
| SCHEMBL7314743 | 0.53 | — | — | |
| SCHEMBL567476 | 0.50 | TRIM24 (0.38) | — | |
| SCHEMBL1053342 | 0.50 | — | — | |
| SCHEMBL567477 | 0.50 | TRIM24 (0.38) | — | |
| SCHEMBL567479 | 0.50 | TRIM24 (0.38) | — | |
| SCHEMBL1495179 | 0.49 | TRIM24 (0.39) | — | |
| SCHEMBL1377292 | 0.49 | TRIM24 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4389130-A1 | APPLICATION OF STEROID COMPOUND IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING EYE FLOATERS | Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. (CN) | 2024-06-26 | — | — | EP | claimed |
| CN-118176004-A | Use of steroid compounds for the prevention and/or treatment of cataracts | 广州润尔眼科生物科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-117693346-A | Application of steroid compound in preparation of medicine for preventing and/or treating mosquito diseases | 广州润尔眼科生物科技有限公司 | 2024-03-12 | — | — | CN | claimed |
| WO-2024017315-A1 | USE OF STEROID COMPOUND IN PREPARATION OF MEDICAMENT FOR PREVENTING AND/OR TREATING OPHTHALMIC DISEASES | 广州润尔眼科生物科技有限公司 | 2024-01-25 | — | — | WO | claimed |
| WO-2023222116-A1 | USE OF STEROID COMPOUND | 广州润尔眼科生物科技有限公司 | 2023-11-23 | — | — | WO | claimed |
| WO-2023198192-A1 | USE OF STEROID COMPOUND IN PREPARING DRUGS FOR PREVENTING AND/OR TREATING PRESBYOPIA | 广州润尔眼科生物科技有限公司 | 2023-10-19 | — | — | WO | claimed |
| WO-2023143452-A1 | APPLICATION OF STEROIDAL COMPOUND IN PREVENTION AND/OR TREATMENT OF CATARACTS | 广州润尔眼科生物科技有限公司 | 2023-08-03 | — | — | WO | claimed |
| CN-115677729-A | AAK1 inhibitors | 武汉人福创新药物研发中心有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-113072521-A | ROR gamma t inhibitor and application thereof in medicine | 广东东阳光药业有限公司 | 2021-07-06 | — | — | CN | claimed |
| CN-108299532-B | Antiviral nucleoside analogue prodrug and composition and application thereof | 广东东阳光药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-112047909-A | Indenyl compound, pharmaceutical composition and medical application thereof | ADT制药有限责任公司 | 2020-12-08 | — | — | CN | claimed |
| CN-112020354-A | Anti-cancer indenes, indanes, aza-indenes, aza-indanes, pharmaceutical compositions and uses | ADT制药有限责任公司 | 2020-12-01 | — | — | CN | claimed |
| CN-110621670-A | Benzazepine analogs as inhibitors of bruton's tyrosine kinase | 比奥根MA公司 | 2019-12-27 | — | — | CN | claimed |
| CN-105085429-B | Aromatic heterocyclic derivative and application thereof in medicines | 广东东阳光药业有限公司 | 2019-12-10 | — | — | CN | claimed |
| CN-118344271-A | Alkoxy substituted benzoyl oxo cyclohexene sulfide compound, preparation method and application thereof | 沈阳万菱生物技术有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118344301-A | Tetra-substituted cyclohexene thioether compound, preparation method and application thereof | 沈阳万菱生物技术有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118344363-A | Tricyclic fused ring derivatives and uses thereof | 广东东阳光药业股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-109251166-A | The aminated compounds for inhibiting SSAO/VAP-1 and its application in medicine | 广东东阳光药业有限公司 | 2019-01-22 | — | — | CN | disclosed |
| WO-2016015605-A1 | COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2016-02-04 | — | — | WO | disclosed |
| US-9181244-B1 | Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitors | Xuanzhu Pharma Co., Ltd. (CN) | 2015-11-10 | — | — | US | disclosed |